What's breaking now, across thousands of outlets.
The Ozempic maker raised its full-year outlook for the third time this year on Wednesday as its Wegovy pill beat third-quarter sales forecasts, boosting the Danish firm's bid to win back ground from US rival Eli Lilly.
We haven't written up this one. Business of Fashion has the full story — the link below goes straight to it.
Last week, Christine Lagarde announced that she would be giving up her position at the ECB as early as this spring. Now the eurozone countries are starting to nominate her successor.
Texas has been considered a safe bet for Republicans for decades. However, dissatisfaction with US President Donald Trump became a major burden. The state is now shining in the blue of the Democrats.
Low wages and duty-free access to key Western markets helped the country become the world’s second-largest apparel exporter. Now protests over pay are testing that cost advantage.
Donald Trump has suffered a historic defeat in the US 2026 midterms, as voters across the country put aside their doubts about pro-Gaza, pro-trans, pro-abortion Democratic candidates who promised to…
The Independent Fiscal Responsibility Authority (Airef) estimates a 5.7% growth in primary spending until 2028, compared to the 3.2% committed to Brussels.
